TWO SIGMA INVESTMENTS, LP - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 42 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$256,000
+39.9%
186,949
+16.5%
0.00%0.0%
Q1 2020$183,000
+60.5%
160,422
+18.5%
0.00%
Q3 2019$114,000
-50.2%
135,373
-42.3%
0.00%
-100.0%
Q2 2019$229,000
-40.2%
234,518
+98.1%
0.00%0.0%
Q4 2018$383,000
+145.5%
118,361
+82.6%
0.00%
Q3 2018$156,000
-41.6%
64,812
-32.3%
0.00%
-100.0%
Q2 2018$267,000
-9.8%
95,797
+54.0%
0.00%0.0%
Q1 2018$296,000
+722.2%
62,223
+266.8%
0.00%
Q3 2017$36,000
-92.9%
16,962
-47.7%
0.00%
-100.0%
Q3 2016$505,00032,4110.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders